Steve E. McCormack

Assistant professor
Hematology, Oncology and Transplantation
HealthPartners Research Foundation
United States of America

Professor Haematology
Biography

Steve E. McCormack is Assistant professor, Department of Hematology, Oncology and Transplantation, University of Minnesota. he completed his MD, University of North Dakota; residency in internal medicine, The Ohio State University; fellowship in hematology and medical oncology, University of Minnesota.

Research Intrest

Dr. McCormack is a sub-investigator for several clinical research studies at Regions Hospital. In addition, he has had his work on acute myeloid leukemia and myelodysplastic syndromes presented in such journals as Leukemia Research and OncoTargets and Therapy.

List of Publications
Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine. McCormack SE, Warlick ED. Onco Targets Ther. 2010 Sep 7;3:157-65.
Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission. McCormack SE, Cao Q, Oran B, Weisdorf DJ, Warlick ED. Leuk Res. 2011 Jun;35(6):757-61.
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial. Joachim A, Bauer A, Joseph S, Geldmacher C, Munseri PJ, Aboud S, Missanga M, Mann P, Wahren B, Ferrari G, Polonis VR, Robb ML, Weber J, Tatoud R, Maboko L, Hoelscher M, Lyamuya EF, Biberfeld G, Sandström E, Kroidl A, Bakari M, Nilsson C, McCormack S. PLoS One. 2016 May 18;11(5):e0155702.